Suchergebnisse - "Alanazi, Hamad H"

PubPharm (13)

1

Editorial : Proteins and protein-complexes underlying mitochondrial structure-function and metabolism: implications in diseases

enthalten in: Frontiers in cell and developmental biology | 2024

von Sabbir, M. | Dar, N. | Bhat, S. | +2

2

Medicinal Herbs : Promising Immunomodulators for the Treatment of Infectious Diseases

enthalten in: Molecules (Basel, Switzerland) | 2023

von Alanazi, H. | Elasbali, A. | Alanazi, M. | +1

3

Antioxidative and ROS-dependent apoptotic effects of Cuscuta reflexa Roxb. stem against human lung cancer : network pharmacology and in vitro experimental validation

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Elasbali, A. | Al-Soud, W. | Mousa Elayyan, A. | +9

4

Actinidia deliciosa Extract as a Promising Supplemental Agent for Hepatic and Renal Complication-Associated Type 2 Diabetes (In Vivo and In Silico-Based Studies)

enthalten in: International journal of molecular sciences | 2023

von El Azab, E. | Alakilli, S. | Saleh, A. | +9

5

Identification of novel c-Kit inhibitors from natural sources using virtual screening and molecular dynamics simulations

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Elasbali, A. | Al-Soud, W. | Elfaki, E. | +6

6

A Sequalae of Lineage Divergence in Staphylococcus aureus from Community-Acquired Patterns in Youth to Hospital-Associated Profiles in Seniors Implied Age-Specific Host-Selection from a Common Ancestor

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Said, K. | AlGhasab, N. | Alharbi, M. | +12

7

Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Elasbali, A. | Al-Soud, W. | Mousa Elayyan, A. | +9

8

The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases

enthalten in: Frontiers in pharmacology | 2023

von Alanazi, H. | Elfaki, E.

9

STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33-driven type 2 immunopathology

enthalten in: JCI insight | 2021

von She, L. | Barrera, G. | Yan, L. | +10

10

Non-canonical Activation of Human Group 2 Innate Lymphoid Cells by TLR4 Signaling

enthalten in: bioRxiv.org | 2020

von She, L. | Alanazi, H. | Wang, J. | +10